Market Place
Sourcing Support
All News #Library
Novo Nordisk’s Wegovy Receives Approval in US
22 Dec 2025 //
FDA
Novo Nordisk’s Biologic Norditropin Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo’s Biologic Norditropin Flexpro Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo’s Biologics Norditropin Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo Nordisk`s Biologics Sogroya Receive Suppl Approval in US
09 Jul 2025 //
FDA
Novo Nordisk`s Biologic Alhemo Receives Approval in US
20 Dec 2024 //
FDA
Novo`s Biologic Fiasp Penfill(Insulin aspart) Receives Approval in the U.S.
21 Jun 2023 //
FDA
Novo`s Biologic Fiasp (Insulin aspart) Receives Approval in the U.S.
21 Jun 2023 //
FDA
Novo`s insulin degludec:Liraglutide Receives Approval in the U.S.
01 Jul 2022 //
FDA
Novo Nordisk insulin degludec:Liraglutide Receives Approval in the U.S.
10 Jun 2022 //
FDA
Novo Nordisk`s Biologic Wegovy (Semaglutide) Receives Approval in Europe
10 Mar 2022 //
EMA
Novo Nordisk`s Rybelsus (Semaglutide) Receives Approval In Europe
10 Jun 2020 //
EMA
Novo Nordisk`s Ozempic (Semaglutide) Receives Approval In Europe
22 Feb 2018 //
EMA
Novo Nordisk’s Refixia Nonacog Beta Pegol Receives Approval In Europe
03 Aug 2017 //
EMA
Novo Nordisk Gets EU Nod For Fiasp (Insulin Aspart)
03 Feb 2017 //
EMA
Novo Nordisk Inc Victoza Approved In US
20 Sep 2016 //
FDA
Novo Nordisk`s Generic Ryzodeg approved in US for Diabetes Mellitus
29 Sep 2015 //
FDA
Novo Nordisk`s Generic Tresiba approved in US for Diabetes Mellitus
29 Sep 2015 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.